Company: SXT
Filing Date: 2025-03-12
Form Type: DEF 14A
Source: 0001140361-25-008248
Chunk: 13

Company: SENSIENT TECHNOLOGIES CORP
Filing Date: 2025-03-12
Form: DEF 14A
Chunk 13
---
, including:

| • | Chemical Risk Reduction Strategy, led by the CEO, Director Dr. Ferruzzi, and SAC member Dr. Eric Decker, which includes improved product warnings and enhanced safety protocols, as well as forward looking risk identification and product elimination; |

| • | A corporate physical security program led by a retired Secret Service Agent, who reports to the General Counsel; this program includes an internal governance council led by the General Counsel; a crisis response team led by the CEO; workplace violence and active assailant prevention and training programs; and a travel security program, which includes the utilization of executive security teams as required. |

| • | A robust EHS program that is managed within the Legal Department; |

| • | A strong Regulatory Affairs department overseen by a Vice President who reports to the General Counsel; |

| • | EHS audits at every manufacturing facility by an outside consulting firm; |

| • | In-house securities attorney; |

| • | In-house compliance attorney who is continually engaged with the business units on FDA, EPA, and OSHA regulatory matters; and |

| • | Legal Department review of all contracts. |

As noted above, the Board also has routine contact with all Company officers and periodically receives presentations from the Group Presidents and Vice Presidents as well as select General Managers.

17

Board Meetings and Meeting Attendance The Company’s Corporate Governance Guidelines provide that all directors are expected to regularly attend meetings of the Board and the committees of which they are members and to attend the Annual Meeting of Shareholders. All Board members attended the 2024 Annual Meeting of Shareholders. The Board met six times during 2024. Each director attended 100% of the meetings of the Board and the Board Committees on which he or she served that were held during 2024 except Ms. McKeithan-Gebhardt was unable to attend one Executive Committee meeting. Committees of the Board Executive Committee The Executive Committee of the Board met two times during 2024. Messrs. Morrison and Paul Manning (Chairman), Dr. Carleone, and Mses. McKeithan-Gebhardt and Whitelaw served on the Executive Committee in 2024 and are its current members. This Committee has the power and authority of the Board in directing the management of the business and affairs of the Company in the intervals between Board meetings, except to the extent limited by law, and reports its actions at regular meetings of the Board. Audit Committee The Audit Committee of the Board met nine times during 2024. Messrs. Jain